Mr. Christopher Timbrell Oborn, M.S., LCMHC, NCC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1472 N Page Bench Rd, Roosevelt, UT 84066 Phone: 385-441-4237 |
Samantha Jo Atwood, LCMHC Counselor - Mental Health Medicare: Medicare Enrolled Practice Location: 285 W 800 S, Roosevelt, UT 84066 Phone: 435-725-6300 Fax: 435-725-6325 |
Rochelle L Danley Counselor Medicare: Medicare Enrolled Practice Location: 285 W 800 S, Roosevelt, UT 84066 Phone: 435-725-6300 Fax: 435-725-6325 |
Beverly Berrett Counselor Medicare: Not Enrolled in Medicare Practice Location: 285 W 800 S, Roosevelt, UT 84066 Phone: 435-725-6300 Fax: 435-725-6325 |
Michele Catten, CSW Counselor Medicare: Not Enrolled in Medicare Practice Location: 285 W 800 S, Roosevelt, UT 84066 Phone: 435-725-6300 |
Jason Norman, LCSW Counselor Medicare: Accepting Medicare Assignments Practice Location: 285 W 800 S, Roosevelt, UT 84066 Phone: 435-725-6300 Fax: 435-725-6325 |
Leslie R Harris Counselor Medicare: Not Enrolled in Medicare Practice Location: 285 W 800 S, Roosevelt, UT 84066 Phone: 435-725-6300 Fax: 435-725-6325 |
Jeremy M Patton Counselor Medicare: Not Enrolled in Medicare Practice Location: 285 W 800 S, Roosevelt, UT 84066 Phone: 435-725-6300 Fax: 435-725-6325 |
News Archive
BioCryst Pharmaceuticals, Inc. today announced that it has delivered a written response to the request for proposal (RFP) announced on September 21, 2009 from the U.S. Department of Health & Human Services (HHS) for the supply of intravenous (i.v) peramivir for the treatment of critically ill influenza patients under Emergency Use Authorization (EUA). BioCryst management intends to provide an update once the RFP process has reached a conclusion.
In individuals with type 2 diabetes, any degree of measurable urinary protein excretion—even in what is considered the normal range—increases their risk of experiencing heart problems, according to a study appearing in an upcoming issue of new study in the Journal of the American Society of Nephrology (JASN).
Retina Implant AG, a leading developer of subretinal implants for the visually impaired, today announced the publication of a peer-reviewed study in Proceedings of the Royal Society B discussing the technical and clinical results obtained during their first human clinical trial.
The escalating costs of cancer care combined with variations in concordance with evidence-based practice guidelines is putting the United States on a collision course for an impending collapse of its current health care system according to roundtable panelists at the NCCN 15th Annual Conference.
Health Canada is warning consumers not to use Thermonex capsules, which are being advertised for weight loss, water loss and to help boost thyroid output. This product could cause serious adverse effects, including death.
› Verified 8 days ago